BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9599905)

  • 1. Antimicrobial resistance: an ecological approach to a growing threat.
    Gordon SM
    Cleve Clin J Med; 1998 May; 65(5):232-6. PubMed ID: 9599905
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial-resistant pathogens in the 1990s.
    Jacoby GA
    Annu Rev Med; 1996; 47():169-79. PubMed ID: 8712771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Cockerill FR; Steckelberg JM
    Diagn Microbiol Infect Dis; 1998 Feb; 30(2):89-92. PubMed ID: 9554174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin resistance gene transfer from Enterococcus faecalis and E. faecium to Staphylococcus aureus, S. intermedius and S. hyicus.
    Noble WC; Rahman M; Karadec T; Schwarz S
    Vet Microbiol; 1996 Sep; 52(1-2):143-52. PubMed ID: 8914258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.
    Liao M; Ruddock PS; Rizvi AS; Hall SH; French FS; Dillon JR
    J Antimicrob Chemother; 2005 Nov; 56(5):957-61. PubMed ID: 16195256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance patterns of important gram-positive pathogens.
    Acar JF; Buu-Hoi AY
    J Antimicrob Chemother; 1988 Apr; 21 Suppl C():41-7. PubMed ID: 3133348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.
    Munckhof WJ; Giles C; Turnidge JD
    J Antimicrob Chemother; 2001 Jun; 47(6):879-83. PubMed ID: 11389123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in Staphylococcus aureus and streptococci.
    Lacey RW
    Br Med Bull; 1984 Jan; 40(1):77-83. PubMed ID: 6442875
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark.
    Aarestrup FM; Agerso Y; Gerner-Smidt P; Madsen M; Jensen LB
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):127-37. PubMed ID: 10863107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs].
    Inoue M; Kubo S; Saito A; Ubukata K; Shimizu Y; Igari J; Watanabe A; Oguri T; Kawai T; Kobayashi Y; Hayashi M; Shiba K; Sakamoto M; Kanno H; Tokue Y; Yamaguchi K; Miyazaki S; Higashitsutsumi M; Sakamoto M; Inamatsu T; Kohno S; Tomono K; Shimada J; Kaku M; Ueda Y
    Jpn J Antibiot; 1999 Apr; 52(4):302-12. PubMed ID: 10396687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of antibiotic resistance.
    Levy SB
    Sci Am; 1998 Mar; 278(3):46-53. PubMed ID: 9487702
    [No Abstract]   [Full Text] [Related]  

  • 12. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus.
    Cunha BA
    Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of novel rifamycins against gram-positive clinical isolates.
    Murphy CK; Karginova E; Sahm D; Rothstein DM
    J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
    Severina E; Severin A; Tomasz A
    J Antimicrob Chemother; 1998 Mar; 41(3):341-7. PubMed ID: 9578160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA.
    Sahm DF; Marsilio MK; Piazza G
    Clin Infect Dis; 1999 Aug; 29(2):259-63. PubMed ID: 10476722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain.
    Ocaña VS; Pesce De Ruiz Holgado AA; Nader-Macías ME
    Appl Environ Microbiol; 1999 Dec; 65(12):5631-5. PubMed ID: 10584033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging patterns of microbial resistance.
    Washington JA
    Orthop Clin North Am; 1984 Jul; 15(3):417-25. PubMed ID: 6433290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility testing of linezolid by two standard methods.
    Hamilton-Miller JM; Shah S
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):225-7. PubMed ID: 10357061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of bacterial endocarditis].
    Halawa B
    Wiad Lek; 1982 Nov; 35(19-20):1257-64. PubMed ID: 6819721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.